Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections

Journal of Vascular Access

Volumn 8, Issue 4, 2007, Pages 262-267

  Takla, T A ^a   Zelenitsky, S A ^a,b   Vercaigne, Lavern M ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c Manitoba Renal Program   (Canada)

Author keywords

Catheters; Hemodialysis; Infection; Vascular access

Indexed keywords

ALCOHOL; CITRATE TRISODIUM;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIALYSIS CATHETER; ESCHERICHIA COLI; GROWTH INHIBITION; HEMODIALYSIS; INFECTION COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; SUSPENSION CELL CULTURE;

EID: 39449108635     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980700800408     Document Type: Article

References (42)

1. Canadian Institute for Health Information: Canadian Organ Replacement Register: 2002 CORR Preliminary Report. http://secure.cihi.ca/cihiweb/en/ downloads/reports_corr2002prelim_e.pdf
2. Canadian Institute for Health Information: Canadian Organ Replacement Register: 2006 Annual Report. http://secure.cihi.ca/cihiweb/products/ corr_annual_report_2006_e.pdf
3. United States Renal Data System: 2006 Annual Data Report: Prevalence of reported ESRD. http://www.usrds.org/2006/ref/B_prevalence_06.pdf
4. United States Renal Data System: 2006 Annual Data Report: Treatment modalities. http://www.usrds.org/2006/ref/D_modality_06.pdf
5. Roy-Chaudhury P, Kelly BS, Melhem M, et al. Vascular access in hemodialysis: issues, management, and emerging concepts. Cardiol Clin 2005; 23: 249-73.
6. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21: 721-8.
7. Buturovic J, Ponikvar R, Kandus A, Bob M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998; 22: 945-7.
8. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999; 56: 1-17.
9. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. AM J Kidney Dis 2004; 44: 779-91.
10. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens 2000; 9: 631-5.
11. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999; 10: 1045-9.
12. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14: 169-79.
13. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127: 275-80.
14. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-24.
15. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13: 2133-9.
16. Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 1999; 14: 1710-4.
17. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136-42.
18. Mokrzycki MH, Schroppel B, von Gersdorff G, Rush H, Zdunek MP, Feingold R. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol 2000; 11: 2122-7.
19. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-5.
20. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19: 1237-44.
21. Saxena AK, Panhotra BR. Haemodialysis catheter-related bloodstream infections: current treatment options and strategies for prevention. Swiss Med Wkly 2005; 135: 127-38.
22. Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19: 670-7.
23. Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000; 57: 2151-5.
24. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
25. Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8: 231-4.
26. Droste JC, Jeraj HA, MacDonald A, Farrington K Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 2003; 51: 849-55.
27. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46: 1674-9.
28. Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif 2001; 19: 251-4.
29. Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-77.
30. Bell AL, Gu X, Burczynski FJ, Vercaigne LM. Ethanol/trisodium citrate for hemodialysis catheter lock. Clin Nephrol 2004; 62: 369-73.
31. Bell AL, Jayaraman R, Vercaigne LM. Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol 2005; 65; 342-8.
32. Weijmer MC, Debets-Ossenkopp, YJ, Van De Vondervoort FJ, ter Wee PM. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002; 17: 2189-95.
33. Ingram LO. Ethanol tolerance in bacteria. Crit Rev Biotechnol 1990; 9: 305-19.
34. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003; 25: 616-21.
35. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect 2004; 49: 20-2.
36. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad, II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006; 50: 1865-8.
37. Ball PA, Brokenshire E, Parry B, et al. Ethanol locking as a possible treatment for microbial contamination of longterm central venous catheters. Nutrition 2003; 19: 570.
38. Karaaslan H, Peyronnet P, Benevent D, Lagarde C, Rince M, Leroux-Robert C. Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 2001; 16: 2072-4.
39. Michaud D, Komant T, Pfefferle P. Four percent trisodium citrate as an alternative anticoagulant for maintaining patency of central venous hemodialysis catheters: case report and discussion. Am J Crit Care 2001; 10: 351-4.
40. US Food and Drug Administration: FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant. http://www.fda.gov/bbs/topics/ANSWERS/ ANS01009.html
41. Stas KJ, Vanwalleghem J, De Moor B, Keuleers H. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis. Nephrol Dial Transplant 2001; 16: 1521-2.
42. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22: 477-83.